H

Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627

Watchlist Manager
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
Watchlist
Price: 4.13 CNY 0.98% Market Closed
Market Cap: 20.4B CNY
Have any thoughts about
Hubei Biocause Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Hubei Biocause Pharmaceutical Co Ltd stock under the Base Case scenario is 4.8 CNY. Compared to the current market price of 4.13 CNY, Hubei Biocause Pharmaceutical Co Ltd is Undervalued by 14%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
4.8 CNY
Undervaluation 14%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation Backtest
Hubei Biocause Pharmaceutical Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Hubei Biocause Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Hubei Biocause Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Insurance Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Hubei Biocause Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Hubei Biocause Pharmaceutical Co Ltd.

What unique competitive advantages
does Hubei Biocause Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Hubei Biocause Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Hubei Biocause Pharmaceutical Co Ltd.

Provide P/S
for Hubei Biocause Pharmaceutical Co Ltd.

Provide P/E
for Hubei Biocause Pharmaceutical Co Ltd.

Provide P/B
for Hubei Biocause Pharmaceutical Co Ltd.

What are the Revenue projections
for Hubei Biocause Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Hubei Biocause Pharmaceutical Co Ltd?

What are the Net Income projections
for Hubei Biocause Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Hubei Biocause Pharmaceutical Co Ltd?

What are the EPS projections
for Hubei Biocause Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Hubei Biocause Pharmaceutical Co Ltd?

What are the EBIT projections
for Hubei Biocause Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Hubei Biocause Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Hubei Biocause Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Hubei Biocause Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Hubei Biocause Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Hubei Biocause Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Hubei Biocause Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Hubei Biocause Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Hubei Biocause Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Hubei Biocause Pharmaceutical Co Ltd.

Provide ROE
for Hubei Biocause Pharmaceutical Co Ltd.

Provide ROA
for Hubei Biocause Pharmaceutical Co Ltd.

Provide Net Margin
for Hubei Biocause Pharmaceutical Co Ltd.

Show all solvency ratios
for Hubei Biocause Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Hubei Biocause Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Hubei Biocause Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Hubei Biocause Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Hubei Biocause Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hubei Biocause Pharmaceutical Co Ltd

Cash & Short-Term Investments 11.8B
Insurance Receivable 1.6B
PP&E 1.5B
Long-Term Investments 209.3B
Other Assets 54.2B
Insurance Policy Liabilities 235.8B
Long Term Debt 5.6B
Other Liabilities 16.5B

Wall St
Price Targets

Price Targets Summary
Hubei Biocause Pharmaceutical Co Ltd

There are no price targets for Hubei Biocause Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Hubei Biocause Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hubei Biocause Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest

Profile

Hubei Biocause Pharmaceutical Co Ltd

Country

China

Industry

Insurance

Market Cap

20.4B CNY

Dividend Yield

0%

Description

Hubei Biocause Pharmaceutical Co., Ltd. is an investment holding company that engages in the insurance industry. The company is headquartered in Jingmen, Hubei and currently employs 2,239 full-time employees. is a China-based company principally engaged in insurance business, such as life insurance, health insurance and casualty insurance. The firm is also involved in pharmaceutical business and chemical business. The Company’s products include polypropylene and Ibuprofen. The firm distributes its products in domestic market and to overseas markets, with Central China and South China as its main markets.

Contact

HUBEI
Jingmen
2F, Building 1, (Guohua Huijin Center), No. 1 Tianshan Road , Zhanghe New District
+867246096558
www.biocause.com

IPO

1996-11-12

Employees

2 239

Officers

Vice Chairman & GM
Ms. Wenxia Zhou
CFO & Director
Mr. Dali Chen
Secretary of the Board & Non-Independent Director
Mr. Fei Long

See Also

Discover More
What is the Intrinsic Value of one Hubei Biocause Pharmaceutical Co Ltd stock?

The intrinsic value of one Hubei Biocause Pharmaceutical Co Ltd stock under the Base Case scenario is 4.8 CNY.

Is Hubei Biocause Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 4.13 CNY, Hubei Biocause Pharmaceutical Co Ltd is Undervalued by 14%.

Back to Top